A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jessica Pollard, MD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S of Alabama/university of Alabama at Birmingham
Birmingham, Alabama, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Benioff Children'S Hospital
San Francisco, California, United States
- Children'S National Hospital
Washington D.C., District of Columbia, United States
- Riley Hospital for Children - Indiana University
Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- St Jude Children'S Research Hospital
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 May 2022
- Primary completion
- 1 Dec 2022
- Completion
- 1 Dec 2022
- Last update posted
- 30 May 2023
- Registered enrollment
- 3
- Registry id
- NCT05077423
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.